Latonya Hickson is a Nephrology physician. OpenAlex indexes 160 publications with 8,379 citations (h-index 41); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 San Pablo Rd S
Jacksonville, FL 322241865
Telephone
904-953-2000Provider last certified this registry record 28 Aug 2020.
Clinical trials
- Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
Sponsor: LaTonya J. Hickson
- Stem Cell Therapy for Chronic Kidney Disease
Sponsor: LaTonya J. Hickson
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
3 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease
Mayo Clinic Jacksonville
FY2026$578,941R01AG076537 - Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease
Mayo Clinic Jacksonville
FY2025$567,364R01AG076537 - Extracellular vesicle-based senotherapeutics for aging diabetic kidneydisease
Mayo Clinic Jacksonville
FY2024$578,941R01AG076537
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
Nature Communications
2022 - Older Patients with Advanced Chronic Kidney Disease and Their Perspectives on Prognostic Information: a Qualitative Study
Journal of General Internal Medicine
2022 - Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy
Journal of the American Society of Nephrology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”